In the world of drug formulation research and nanotechnology, lipid-based delivery systems have captured the attention of scientists aiming to
According to the latest market report about liposome and nanoparticle drug delivery, the market size and market share continue to
In recent years, great achievements have been made in the development of drug delivery systems, which bring potential therapeutics for
A novel liposome product, doxorubicin hydrocholoride liposomal injection, has received FDA approval as well as European Commission authorization to be used in the treatment of
International trade plays a vital role in the Canadian economy, and businesses that import or export goods must comply with
In the rapidly evolving landscape of cancer immunotherapy, Cytokine-Induced Killer (CIK) cell therapy is gaining traction as a promising
Targeting lung adenocarcinoma involves using DNA aptamers—short, single-stranded oligonucleotides—that bind specifically to malignant cells and tissues. Lung adenocarcinoma is the
Targeting multiple myeloma cells (MM.1S) involves using aptamers—short, single-stranded DNA molecules—that bind specifically to surface markers on malignant plasma cells.
The complement system is a critical component of the innate immune system, orchestrating a cascade of reactions to recognize and
Alzheimer’s disease (AD) is a common neurodegenerative encephalopathy which occurs in pre- and post-elderly conditions with a gradual loss of
